اثربخشی درمان مبتنی بر پذیرش و تعهد بر کمالگرایی و کیفیت زندگی در بیماران مبتلاء به اختلال وسواس فکری ـ عملی
محورهای موضوعی : روانشناسیمریم عزتپور 1 , زهرا تنها 2 , کوروش امرایی 3 , کوروش گودرزی 4
1 - گروه روانشناسی، واحد بروجرد، دانشگاه آزاد اسلامی، بروجرد، ایران mohammadianamiriakram@gmail.com
2 - (نویسنده مسئول)، استادیار، گروه روان¬شناسی، دانشکده ادبیات و علوم انسانی، واحد خرم آباد، دانشگاه آزاد اسلامی، خرم آباد، ایران. zahratanha21362@yahoo.com , tell: 09166611309
3 - دانشیار، گروه روانشناسی، دانشکده ادبیات و علوم انسانی، دانشگاه لرستان، خرم آباد، ایران kouroshamraei3@yahoo.com
4 - گروه روانشناسی، واحد بروجرد، دانشگاه آزاد اسلامی، بروجرد، ایران kourosh4goodarzi4@yahoo.com
کلید واژه: اختلال وسواس فکری عملی, درمان مبتنی بر پذیرش و تعهد, کمال گرایی, کیفیت زندگی ,
چکیده مقاله :
چکیده مقدمه: درمان مبتنی¬ بر پذیرش و تعهد می¬تواند بر بسیاری از نشانه¬ها و تظاهرات بالینی اختلال وسواس فکری و عملی، مثلاً اجتناب، بازداری فکر، کیفیت زندگی مختل و مشکلات خلقی، تأثیر مثبت بگذارد. این پژوهش با هدف، بررسی اثربخشی درمان مبتنی بر پذیرش و تعهد بر کمالگرایی و کیفیت زندگی در بیماران مبتلاء به اختلال وسواس فکری عملی انجام شد. روش پژوهش: این پژوهش، از نوع نیمه آزمایشی با طرح پیش آزمون، پس آزمون و پیگیری با گروه کنترل بود. جامعه آماری پژوهش شامل، کلیه بیماران بیمارستان اعصاب و روان مهر، امام رضا و مرکز بهداشت خرم آباد در نیمه دوم سال 1402 بودند که از این جامعه 30 شرکت کننده به صورت نمونه گیری در دسترس انتخاب و در گروه‌های آزمایش و کنترل قرار داده شدند و به پرسشنامه‌های کمالگرایی هیل و همکاران و پرسشــنامه کیفیــت زنــدگی وار و شــربوم در 3 مرحله پاسخ دادند و برای گروه مداخله طی 8 جلسه بر اساس پروتکل درمانی برنامه‌ریزی شد و گروه کنترل آموزشی دریافت نکردند و داده‌های بدست آمده توسط تحلیل واریانس با اندازه گیری مکرر مورد تجزیه و تحلیل قرار گرفت. یافته‌ها: نتایج نشان داد، درمان مبتنی بر پذیرش و تعهد بر بعد ناسازگارانه (004/0=P) کمالگرایی و بر بعد سلامت روانی کیفیت زندگی(047/0=P) معنادار است. نتیجه‌گیری: بر این اساس چنین نتیجه گیری شد درمان مبتنی بر پذیرش و تعهد روش موثری برای کاهش کمالگرایی ناسازگارانه و افزایش بعد سلامت روان کیفیت زندگی در بیماران مبتلاء به اختلال وسواس فکری عملی است.
Abstract Introduction: Treatment based on acceptance and commitment can have a positive effect on many symptoms and clinical manifestations of obsessive-compulsive disorder, such as avoidance, thought inhibition, impaired quality of life, and mood problems. This research was conducted with the aim of investigating the effectiveness of treatment based on acceptance and commitment on perfectionism and quality of life in patients with obsessive-compulsive disorder. Research method: This research was a semi-experimental type with a pre-test, post-test and follow-up design with a control group. The statistical population of the research included all the patients of Mehr Neurological and Psychiatric Hospital, Imam Reza and Khorramabad Health Center in the second half of 1402, and 30 participants were selected from this population by available sampling and placed in experimental and control groups. They responded to the perfectionism questionnaires of Hill et al. and the quality of life questionnaire of War and Sherboom in 3 stages, and for the intervention group, 8 sessions were planned based on the treatment protocol, and the control group did not receive training, and the data obtained by variance analysis It was analyzed by repeated measures. Findings: The results showed that the treatment based on acceptance and commitment is significant on the maladaptive dimension of perfectionism (P=0.004) and on the mental health dimension of quality of life (P=0.047). Conclusion: Based on this, it was concluded that treatment based on acceptance and commitment is an effective method to reduce maladaptive perfectionism and increase the mental health dimension of quality of life in patients with obsessive-compulsive disorder.
1. Singh A, Anjankar VP, Sapkale B. Obsessive-Compulsive Disorder (OCD): A Comprehensive Review of Diagnosis, Comorbidities, and Treatment Approaches. Cureus. 2023 Nov 17; 15(11):e48960. doi: 10.7759/cureus.48960. PMID: 38111433; PMCID: PMC10726089.
2. Jalal B, Chamberlain SR, Sahakian BJ. Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction. Brain Behav. 2023 Jun; 13(6):e3000. doi: 10.1002/brb3.3000. Epub 2023 May 3. PMID: 37137502; PMCID: PMC10275553.
3. Fairbrother N, Albert A, Keeney C, Tchir D, Cameron RB. Screening for Perinatal OCD: A Comparison of the DOCS and the EPDS. Assessment. 2023 Jun; 30(4):1028-1039. doi: 10.1177/10731911211063223. Epub 2021 Dec 30. PMID: 34969305; PMCID: PMC10152558.
4. Brock H, Hany M. Obsessive-Compulsive Disorder. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31985955.
5. Farrell LJ, Waters AM, Storch EA, Simcock G, Perkes IE, Grisham JR, Dyason KM, Ollendick TH. Closing the Gap for Children with OCD: A Staged-Care Model of Cognitive Behavioural Therapy with Exposure and Response Prevention. Clin Child Fam Psychol Rev. 2023 Sep; 26(3):642-664. doi: 10.1007/s10567-023-00439-2. Epub 2023 Jul 5. PMID: 37405675; PMCID: PMC10465687.
6. Abramowitz A, Abramowitz JS, McKay D, Cham H, Anderson KS, Farrell LJ, Geller DA, Hanna GL, Matheiw S, McGuire JF, Rosenberg DR, Stewart E, Storch E, Wilhelm S. The OCI-CV-R: A revision of the obsessive-compulsive inventory-child version. Journal of Anxiety Disorders. 2022 doi: 10.1016/j.janxdis.2022.102532.
7. Pitsikas N. The role of nitric oxide (NO) modulators in obsessive-compulsive disorder (OCD). Nitric Oxide. 2023 May 1; 134-135:38-43. doi: 10.1016/j.niox.2023.04.001. Epub 2023 Apr 6. PMID: 37028750.
8. Mulcahy M, Long C, Morrow T, Galbally M, Rees C, Anderson R. Consensus recommendations for the assessment and treatment of perinatal obsessive-compulsive disorder (OCD): A Delphi study. Arch Women's Ment Health. 2023 Jun; 26(3):389-399. doi: 10.1007/s00737-023-01315-2. Epub 2023 May 3. PMID: 37138166; PMCID: PMC10155656.
9. Audet JS, Bourguignon L, Aardema F. What makes an obsession? A systematic-review and meta-analysis on the specific characteristics of intrusive cognitions in OCD in comparison with other clinical and non-clinical populations. Clin Psychol Psychother. 2023 Nov-Dec; 30(6):1446-1463. doi: 10.1002/cpp.2887. Epub 2023 Jul 22. PMID: 37482945.
10. Poli A, Costa DLDC, Grados MA. Editorial: Clinical guidelines in OCD: applications and evaluation. Front Psychiatry. 2024 Feb 7; 15: 1373923. doi: 10.3389/fpsyt.2024.1373923. PMID: 38384591; PMCID: PMC10879564.
11. Luginaah NA, Batung ES, Ziegler BR, Amoak D, Trudell JP, Arku G, Luginaah I. The Parallel Pandemic: A Systematic Review on the Effects of the COVID-19 Pandemic on OCD among Children and Adolescents. Int J Environ Res Public Health. 2023 Nov 22; 20(23):7095. doi: 10.3390/ijerph20237095. PMID: 38063525; PMCID: PMC10706205.
12. Drugs to Treat Anxiety Disorders and Obsessive Compulsive Disorder (OCD). J Psychosoc Nurs Ment Health Serv. 2023 May; 61(5):5-6. doi: 10.3928/02793695-20230324-79. Epub 2023 May 1. PMID: 37129877.
13. Leuchter JD, Kook M, Geller DA, Hertz AG, Garcia J, Trent ES, Dibbs T, Onyeka O, Goodman WK, Guzick AG, Wiese AD, Palo AD, Small BJ, Simpson HB, Havel LK, Nibras SA, Saxena K, Storch EA. Promoting OCD WEllness and resilience (POWER) study: Rationale, design, and methods. Psychiatry Res Commun. 2023 Jun; 3(2):100111. doi: 10.1016/j.psycom.2023.100111. Epub 2023 Mar 11. PMID: 37377947; PMCID: PMC10299759.
14. Killian G, Wagner RD, Plain M, Chhabra AB. A Comparison of Treatment of OCD Lesions of the Capitellum with Osteochondral Autograft and Allograft Transplantation. J Hand Surg Am. 2024 Feb; 49(2): 150-159. doi: 10.1016/j.jhsa.2023.08.012. Epub 2023 Oct 20. PMID: 37865912.
15. Singh A, Anjankar VP, Sapkale B. Obsessive-Compulsive Disorder (OCD): A Comprehensive Review of Diagnosis, Comorbidities, and Treatment Approaches. Cureus. 2023 Nov 17; 15(11):e48960. doi: 10.7759/cureus.48960. PMID: 38111433; PMCID: PMC10726089.
16. Shobeiri P, Hosseini Shabanan S, Haghshomar M, Khanmohammadi S, Fazeli S, Sotoudeh H, Kamali A. Cerebellar Microstructural Abnormalities in Obsessive-Compulsive Disorder (OCD): a Systematic Review of Diffusion Tensor Imaging Studies. Cerebellum. 2024 Apr; 23(2):778-801. doi: 10.1007/s12311-023-01573-x. Epub 2023 Jun 8. PMID: 37291229.
17. Żerdziński M, Burdzik M, Żmuda R, Witkowska-Berek A, Dȩbski P, Flajszok-Macierzyńska N, Piegza M, John-Ziaja H, Gorczyca P. Sense of happiness and other aspects of quality of life in patients with obsessive-compulsive disorder. Front Psychiatry. 2022 Dec 21; 13: 1077337. doi: 10.3389/fpsyt.2022.1077337. PMID: 36620674; PMCID: PMC9810625.
18. Latif K, Nishida T, Moghimi S, Weinreb RN. Quality of life in glaucoma. Graefes Arch Clin Exp Ophthalmol. 2023 Oct; 261(10):3023-3030. doi: 10.1007/s00417-023-06050-z. Epub 2023 Apr 5. PMID: 37017741.
19. McNicholas B, Akcan Arikan A, Ostermann M. Quality of life after acute kidney injury. Curr Opin Crit Care. 2023 Dec 1; 29(6):566-579. doi: 10.1097/MCC.0000000000001090. Epub 2023 Sep 21. PMID: 37861184.
20. Salavera C, Urbón E. Emotional wellbeing in teachers. Acta Psychol (Amst). 2024 May; 245:104218. doi: 10.1016/j.actpsy.2024.104218. Epub 2024 Mar 16. PMID: 38493712.
21. Hayes SC, Villatte M, Levin M, Hildebrandt M. Open, aware, and active: contextual approaches as an emerging trend in the behavioral and cognitive therapies. Annu Rev Clin Psychol. 2011; 7: 141-68. doi: 10.1146/annurev-clinpsy-032210-104449. PMID: 21219193.
22. Zhang Y, Ding Y, Chen X, Li Y, Li J, Hu X. Effectiveness of acceptance and commitment therapy on psychological flexibility, fatigue, sleep disturbance, and quality of life of patients with cancer: A meta-analysis of randomized controlled trials. Worldviews Evid Based Nurs. 2023 Dec; 20(6):582-592. Doi: 10.1111/wvn.12652. Epub 2023 May 16. PMID: 37194163.
23. Fawson S, Moon Z, Novogrudsky K, Moxham F, Forster K, Tribe I, Moss-Morris R, Johnson C, Hughes LD. Acceptance and commitment therapy processes and their association with distress in cancer: a systematic review and meta-analysis. Health Psychol Rev. 2023 Sep 25:1-22. doi: 10.1080/17437199.2023.2261518. Epub ahead of print. PMID: 37746724.
24. Martinez-Calderon J, García-Muñoz C, Rufo-Barbero C, Matias-Soto J, Cano-García FJ. Acceptance and Commitment Therapy for Chronic Pain: An Overview of Systematic Reviews with Meta-Analysis of Randomized Clinical Trials. J Pain. 2024 Mar; 25(3):595-617. doi: 10.1016/j.jpain.2023.09.013. Epub 2023 Sep 23. PMID: 37748597.
25. Gibson Watt T, Gillanders D, Spiller JA, Finucane AM. Acceptance and Commitment Therapy (ACT) for people with advanced progressive illness, their caregivers and staff involved in their care: A scoping review. Palliat Med. 2023 Sep; 37(8):1100-1128. doi: 10.1177/02692163231183101. Epub 2023 Jul 25. PMID: 37489074; PMCID: PMC10503261.
26. Williams AJ, Botanov Y, Giovanetti AK, Perko VL, Sutherland CL, Youngren W, Sakaluk JK. A Metascientific Review of the Evidential Value of Acceptance and Commitment Therapy for Depression. Behav Ther. 2023 Nov; 54(6):989-1005. doi: 10.1016/j.beth.2022.06.004. Epub 2022 Jun 26. PMID: 37863589.
27. Maunick B, Skvarc D, Olive L, Mikocka-Walus A. Effects of acceptance and commitment therapy on fatigue for patients with cancer and other chronic health conditions: A systematic review and meta-analysis. J Psychosom Res. 2023 Aug; 171: 111366. doi: 10.1016/j.jpsychores.2023.111366. Epub 2023 May 16. PMID: 37270911.
28. Ziapour A, Hajiazizi A, Ahmadi M, Dehghan F. Effect of short-term dynamic psychotherapy on sexual function and marital satisfaction in women with depression: Clinical trial study. Health Sci Rep. 2023 Jun 23; 6(6):e1370. doi: 10.1002/hsr2.1370. PMID: 37359406; PMCID: PMC10288974.
29. Heshmati R, Wienicke FJ, Driessen E. The effects of intensive short-term dynamic psychotherapy on depressive symptoms, negative affect, and emotional repression in single treatment-resistant depression: A randomized controlled trial. Psychotherapy (Chic). 2023 Dec; 60(4):497-511. doi: 10.1037/pst0000500. Epub 2023 Oct 16. PMID: 37843533.
30. Shafiei F, Dehghani M, Lavasani FF, Manouchehri M, Mokhtare M. Intensive short-term dynamic psychotherapy for irritable bowel syndrome: a randomized controlled trial examining improvements in emotion regulation, defense mechanisms, quality of life, and IBS symptoms. Front Psychol. 2024 Mar 28; 15: 1293150. doi: 10.3389/fpsyg.2024.1293150. PMID: 38605838; PMCID: PMC11008577.
31. Leiper R., Maltby M. The psychodynamic approach to therapeutic change. London: Sage, 2004.
32. Crowe M, Manuel J, Carlyle D, Lacey C. Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy? Int J Ment Health Nurs. 2023 Dec; 32(6):1766-1772. doi: 10.1111/inm.13214. Epub 2023 Aug 17. PMID: 37589380.
33. Shahverdi ZA, Dehghani M, Ashouri A, Manouchehri M, Mohebi N. Effectiveness of intensive short-term dynamic psychotherapy for Tension-Type Headache (TTH): A randomized controlled trial of effects on emotion regulation, anger, anxiety, and TTH symptom severity. Acta Psychol (Amst). 2024 Apr; 244: 104176. doi: 10.1016/j.actpsy.2024.104176. Epub 2024 Feb 7. PMID: 38330733.
34. Caldiroli A, Capuzzi E, Riva I, Russo S, Clerici M, Roustayan C, Abbass A, Buoli M. Efficacy of intensive short-term dynamic psychotherapy in mood disorders: A critical review. J Affect Disord. 2020 Aug 1; 273: 375-379. doi: 10.1016/j.jad.2020.04.002. Epub 2020 May 13. PMID: 32560931.
35. Hill C. The development of obsessive beliefs: The influence of parents’ beliefs and parenting style characteristics. A thesis submitted to the faculty of the University of North Carolina; 2009.
36. Jamshidy B., Validation of new measure of perfectionism. International Journal of Behavioral Sciences, 2009; 3(1): 35-43.
37. Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF-36). Medical Care 1992; 30(6): 473-483.
38. Watt T, Cramon P, Frendl DM, Ware JE, Group T. Assessing health-related quality of life in patients with benign non-toxic goitre. Best Practice & Research Clinical Endocrinology & Metabolism. 2014; 28(4): 559-75.
